Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease



Status:Active, not recruiting
Conditions:Gastrointestinal, Crohns Disease
Therapuetic Areas:Gastroenterology
Healthy:No
Age Range:18 - 75
Updated:3/3/2019
Start Date:September 2013
End Date:April 2019

Use our guide to learn which trials are right for you!

A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease

The investigators hypothesize that RHB-104 will have greater efficacy than placebo in Crohn's
disease.

A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess
the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects with Moderately to
Severely Active Crohn's Disease.

Inclusion Criteria

1. Signed fully informed consent provided as per this protocol.

2. Diagnosis of Crohn's Disease confirmed by endoscopy or radiography and/or histology at
least 6 months prior to randomization into the study.

3. CD involving the ileum and/or colon

4. Moderately to severely active CD (Crohn's Disease Activity Index (CDAI) score of
greater than or equal to 220 and less than or equal to 450) at baseline.

5. Current treatment with at least one of the following therapies:

A. Oral 5-acetyl salicylic acid (5-ASA) compounds. Dose must be stable for at least 4
weeks before baseline.

B. Corticosteroid therapy. Dose must be stable for at least 2 weeks before baseline.

C. Azathioprine or 6-mercaptopurine (6-MP) or methotrexate. Dose must be stable for at
least 8 weeks before baseline.

D. Infliximab or adalimumab. Dose must be stable for at least 14 weeks before
baseline.

6. White blood cell count greater than or equal to 3.5 x 109 at screening.

7. Active Crohn's disease, defined by at least one of the following: C-reactive protein
greater than Upper Limit of Normal (ULN) at screening, fecal calprotectin greater than
Upper Limit of Normal (ULN) at screening, OR radiographic (MRE or CTE) or endoscopic
confirmation of the presence of active CD within 5 weeks of screening visit. .

8. Subject agrees to use barrier contraceptive methods (i.e. diaphragm, cervical cap,
contraceptive sponge or condom) with spermicidal foam/gel/cream/suppository, IUD/IUS
or progestogen injection (Depo-Provera®) throughout the study and for at least 6 weeks
after last study drug administration, unless subject is post-menopausal or otherwise
incapable of becoming pregnant by reason of surgery or tubal ligation, or has had a
vasectomy. In regions where local regulatory contraceptive requirements differ, the
ICF will reflect local policies.

Exclusion Criteria

1. Crohn's Disease involvement isolated to the mouth, upper gastrointestinal tract, or
anus.

2. History of total colectomy with ileorectal anastomosis or a proctocolectomy.

3. Presence of active fistulizing Crohn's Disease or healed fistula within 2 months prior
to screening.

4. Subject has postoperative stoma, ostomy, or ileoanal pouch.

5. Subject has short bowel syndrome.

6. Subject is scheduled for surgical bowel resection.

7. Subject has known symptomatic obstructive strictures or bowel perforation in the 6
months prior to screening.

8. Change in dose or discontinuation of oral 5-acetyl salicylic acid (5-ASA) compounds
less than 4 weeks prior to baseline.

9. Change in dose or discontinuation of corticosteroids less than 2 weeks prior to
baseline.

10. Change in dose or discontinuation of azathioprine, 6-mercaptopurine (6-MP) or
methotrexate less than 8 weeks prior to baseline.

11. Change in dose or discontinuation of infliximab or adalimumab less than 14 weeks prior
to baseline.

12. Treatment with vedolizumab less than 120 days prior to baseline or biological
therapies (apart from infliximab or adalimumab) less than 60 days prior to baseline.

13. Previous treatment with rifabutin and/or clofazimine.

14. Oral or parenteral antibiotics in the 4 weeks prior to baseline (topical antibiotics
are permitted).

15. Treatment with probiotics (excluding yogurt and yogurt-derived products) in the 4
weeks prior to baseline.

16. Females who have a positive pregnancy test or are lactating.
We found this trial at
44
sites
Richardson, Texas 75082
Principal Investigator: Harry Sarles, Jr, MD
Phone: 214-918-2170
?
mi
from
Richardson, TX
Click here to add this to my saved trials
2147 Northeast Coachman Road
Clearwater, Florida 33765
Principal Investigator: Michael Weiss, MD
Phone: 727-466-0078
?
mi
from
Clearwater, FL
Click here to add this to my saved trials
Anaheim, California 92801
Principal Investigator: Dennis Riff, MD
Phone: 714-774-7777
?
mi
from
Anaheim, CA
Click here to add this to my saved trials
Annapolis, Maryland 21401
Principal Investigator: Michael Epstein, MD
Phone: 410-224-4887
?
mi
from
Annapolis, MD
Click here to add this to my saved trials
Aventura, Florida 33180
Principal Investigator: Isaac Bassan, MD
Phone: 786-202-0998
?
mi
from
Aventura, FL
Click here to add this to my saved trials
Bankstown, New South Wales 2200
Principal Investigator: Rupert Leong, MD
Phone: 61-2-9722-8794
?
mi
from
Bankstown,
Click here to add this to my saved trials
Belton, Missouri 64012
Principal Investigator: Michael Connor, MD
Phone: 816-318-8488
?
mi
from
Belton, MO
Click here to add this to my saved trials
189 Quincy Street
Brockton, Massachusetts 02302
Principal Investigator: Mark Finkelstein, MD
Phone: 508-588-9900
?
mi
from
Brockton, MA
Click here to add this to my saved trials
?
mi
from
Bronx, NY
Click here to add this to my saved trials
Chapel Hill, North Carolina 27599
Principal Investigator: Hans Herfarth, MD, PhD
Phone: 919-843-3873
?
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
6035 Shallowford Road
Chattanooga, Tennessee 37421
Principal Investigator: Richard Krause, MD
Phone: 423-698-4584
?
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Chevy Chase, Maryland 20815
Principal Investigator: Robert Hardi, MD
Phone: 301-652-5520
?
mi
from
Chevy Chase, MD
Click here to add this to my saved trials
1653 W. Congress Parkway
Chicago, Illinois 60612
(312) 942-5000
Principal Investigator: Ece Mutlu, MD
Phone: 312-563-3907
Rush University Medical Center Rush University Medical Center encompasses a 664-bed hospital serving adults and...
?
mi
from
Chicago, IL
Click here to add this to my saved trials
Cincinnati, Ohio 45219
Principal Investigator: Alan Safdi, MD
Phone: 513-872-4549
?
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Cincinnati, Ohio 45219
Principal Investigator: Christopher South, MD
Phone: 513-587-0410
?
mi
from
Cincinnati, OH
Click here to add this to my saved trials
2665 North Decatur Road
Decatur, Georgia 30033
Principal Investigator: David Rausher, MD
Phone: 404-296-1986
?
mi
from
Decatur, GA
Click here to add this to my saved trials
Egg Harbor Township, New Jersey 08324
?
mi
from
Egg Harbor Township, NJ
Click here to add this to my saved trials
Fairfax, Virginia 22031
Principal Investigator: Keith Mirkin, MD
Phone: 703-698-8960
?
mi
from
Fairfax, VA
Click here to add this to my saved trials
Fort Sam Houston, Texas 78284
Principal Investigator: John G. Gancayco, MD
Phone: 210-916-3879
?
mi
from
Fort Sam Houston, TX
Click here to add this to my saved trials
600 Northern Boulevard
Great Neck, New York 11021
Principal Investigator: Keith Sultan, MD
Phone: 516-387-3912
?
mi
from
Great Neck, NY
Click here to add this to my saved trials
Great Neck, New York 11021
Principal Investigator: Robert Tepper, MD
Phone: 516-466-1051
?
mi
from
Great Neck, NY
Click here to add this to my saved trials
Hamden, Connecticut 06518
Principal Investigator: Philip Ginsburg, MD
Phone: 203-281-5161
?
mi
from
Hamden, CT
Click here to add this to my saved trials
Houston, Texas 77030
Principal Investigator: Jason Hou, MD
Phone: 713-798-7616
?
mi
from
Houston, TX
Click here to add this to my saved trials
Houston, Texas 77030
Principal Investigator: Nirav Thosani, MD
Phone: 713-500-6654
?
mi
from
Houston, TX
Click here to add this to my saved trials
Humble, Texas 77036
Principal Investigator: Ravi Moparty, MD
Phone: 281-583-5000
?
mi
from
Humble, TX
Click here to add this to my saved trials
15627 Imperial Highway
La Mirada, California 90638
Principal Investigator: Richard McGuire, MD
Phone: 562-479-0330
?
mi
from
La Mirada, CA
Click here to add this to my saved trials
Lauderdale Lakes, Florida 33319
Principal Investigator: Jeffrey Schneider, MD
Phone: 954-915-9991
?
mi
from
Lauderdale Lakes, FL
Click here to add this to my saved trials
Marietta, Georgia 30060
Principal Investigator: Aasim Sheikh, MD
Phone: 678-819-4237
?
mi
from
Marietta, GA
Click here to add this to my saved trials
Naples, Florida 34102
Principal Investigator: Raymond W Phillips, MD
Phone: 239-649-1336
?
mi
from
Naples, FL
Click here to add this to my saved trials
New Port Richey, Florida 34653
Principal Investigator: Curtis Freedland, MD
Phone: 727-835-3261
?
mi
from
New Port Richey, FL
Click here to add this to my saved trials
New York, New York 10016
Principal Investigator: Ian Lustbader, MD
Phone: 917-409-3933
?
mi
from
New York, NY
Click here to add this to my saved trials
1817 North Mills Avenue
Orlando, Florida 32802
Principal Investigator: William Ruderman, MD
Phone: 407-241-3289
?
mi
from
Orlando, FL
Click here to add this to my saved trials
Port Orange, Florida 32127
Principal Investigator: Ammar Hemaidan, MD
Phone: 386-767-8800
?
mi
from
Port Orange, FL
Click here to add this to my saved trials
1201 Broad Rock Boulevard
Richmond, Virginia 23249
Principal Investigator: William Pandak, MD
Phone: 804-675-6789
?
mi
from
Richmond, VA
Click here to add this to my saved trials
621 Camden Street
San Antonio, Texas 78215
Principal Investigator: Ravi Ganeshappa, MD
Phone: 210-614-1234
?
mi
from
San Antonio, TX
Click here to add this to my saved trials
1000 Laurel Street
San Carlos, California 94070
Principal Investigator: Scott Levenson, MD
Phone: 650-596-8800
?
mi
from
San Carlos, CA
Click here to add this to my saved trials
718 Teaneck Road
Teaneck, New Jersey 07666
Principal Investigator: Mitchell Spinnel, MD
Phone: 201-541-6384
?
mi
from
Teaneck, NJ
Click here to add this to my saved trials
Topeka, Kansas 66606
Principal Investigator: Thomas Welton, MD
Phone: 785-270-4881
?
mi
from
Topeka, KS
Click here to add this to my saved trials
Troy, Michigan 48098
Principal Investigator: Sante Bologna, MD
Phone: 248-267-8485
?
mi
from
Troy, MI
Click here to add this to my saved trials
Tucson, Arizona 85710
Principal Investigator: Gary Gottlieb, MD
Phone: 520-635-4515
?
mi
from
Tucson, AZ
Click here to add this to my saved trials
Tyler, Texas 75701
Principal Investigator: George DuVall, MD
Phone: 903-595-5101
?
mi
from
Tyler, TX
Click here to add this to my saved trials
Urbana, Illinois 61801
Principal Investigator: Glenn Gordon, MD
Phone: 217-326-0156
?
mi
from
Urbana, IL
Click here to add this to my saved trials
1835 Knoll Drive
Ventura, California 93003
Principal Investigator: Sabine Hazan, MD
Phone: 805-339-0549
?
mi
from
Ventura, CA
Click here to add this to my saved trials
Wyoming, Michigan 49519
Principal Investigator: Allan Coates, DO
Phone: 616-328-5319
?
mi
from
Wyoming, MI
Click here to add this to my saved trials